Your browser doesn't support javascript.
loading
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma.
Li, Ning; Wu, Tao; Hong, Yong-Gui; Guo, Yan-Zhen; Cheng, Yu-Feng; Ma, Yi-Jie; Bie, Liang-Yu; Cui, Dong-Hai; Gao, Xiao-Hui; Tan, Bing-Xu; Li, Bao-Sheng; Luo, Su-Xia; Wang, Jun-Sheng.
Afiliação
  • Li N; Department of Medical Oncology, The Afliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, NO. 127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan Province, China.
  • Wu T; Department of Internal Medicine, Anyang Tumor Hospital, No. 1 Huanbin North Road, Beiguan District, Anyang, 455000, Henan Province, China.
  • Hong YG; Department of Internal Medicine, Anyang Tumor Hospital, No. 1 Huanbin North Road, Beiguan District, Anyang, 455000, Henan Province, China.
  • Guo YZ; Department of Medical Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471000, China.
  • Cheng YF; Department of Radiotherapy, Qilu Hospital of Shandong University, Jinan, 250012, China.
  • Ma YJ; Department of Medical Oncology, The Afliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, NO. 127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan Province, China.
  • Bie LY; Department of Medical Oncology, The Afliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, NO. 127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan Province, China.
  • Cui DH; Department of Internal Medicine, Anyang Tumor Hospital, No. 1 Huanbin North Road, Beiguan District, Anyang, 455000, Henan Province, China.
  • Gao XH; Department of Medical Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471000, China.
  • Tan BX; Department of Radiotherapy, Qilu Hospital of Shandong University, Jinan, 250012, China.
  • Li BS; Department of Radiotherapy, Shandong Cancer Hospital, Jinan, 250117, China.
  • Luo SX; Department of Medical Oncology, The Afliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, NO. 127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan Province, China. luosxrm@163.com.
  • Wang JS; Department of Internal Medicine, Anyang Tumor Hospital, No. 1 Huanbin North Road, Beiguan District, Anyang, 455000, Henan Province, China. 1207741934@qq.com.
BMC Med ; 20(1): 472, 2022 12 08.
Article em En | MEDLINE | ID: mdl-36482345
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China